Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Guangdong Provincial People'S Hospital
Guangzhou, Guangdong, China
Kun Wang - the First Affiliated Hospital, Sun Yat-Sen University (fah-Sysu)
Guangzhou, Guangdong, China
Ying Lin - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Cuizhi Geng - the First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
Limin Wei - Nanyang Central Hospital
Nanyang, Henan, China
Hao Zhang - the West China Second University Hospital of Sichuan University (wcsuh- Scu)
Chengdu, Sichuan, China
Rutie Yin - Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
Jihui HaoJin Zhang - Affiliated Hospital of Jiaxing University
Jiaxing, Zhejiang, China
Caiping Chen
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2025
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2032
- Last update posted
- 28 Nov 2025
- Registered enrollment
- 188
- Registry id
- NCT07246317
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.